Skip to main content
Caplight Logo









Glycotope GmbH

Glycotope GmbH

Private

Last Round

VC Round

Oct 8, 2015

Company Overview

Glycotope GmbH is a biotechnology company that develops tumor-specific monoclonal antibodies for cancer therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibodiesglycobiologycancer therapytumor-associated antigensdrug discoveryimmunotherapyprecision medicinebiotech licensingoncology pipelineantibody therapeuticsbiologicstherapeutic antibodiescancer drug developmentmAbtargeted cancer therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Glycotope GmbH Comparables

Compare Glycotope GmbH with similar companies based on industry and business-model similarity.

Glycotope GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GO Therapeutics
85%
BioInvent International
77%
GlycoTherapeutics
75%

Glycotope GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 8, 2015
VC RoundMar 11, 2014
VC RoundNov 16, 2007

Key People

Founding team and executive leadership

Roman Rammelt

CEO

Executive Team

Glycotope GmbH Investors

Notable investors and investment history

Glycotope GmbH investors
InvestorRounds
ELSA Eckert Life Science Accelerator GmbHVC Round, Seed
ELSA Eckert Life Science AcceleratorVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 25% QoQ, from 24 to 30 employees.

  • Jan 20, 2026

    Monthly visitors increased 135% MoM, reaching 8.9K.

Glycotope GmbH Filings

Explore SEC and related filing metadata, where available.

Glycotope GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Glycotope GmbH's valuation, stock price, and market status.

Is Glycotope GmbH a public or private company?

Glycotope GmbH is a private company.

What is the current stock price of Glycotope GmbH?

Glycotope GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Glycotope GmbH worth (valuation)?

Valuation information for Glycotope GmbH is not publicly available.

Can I buy Glycotope GmbH stock?

Glycotope GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Glycotope GmbH's last funding round?

Glycotope GmbH's most recent funding round was Strategic on October 8, 2015.

Who are the main investors in Glycotope GmbH?

Key investors in Glycotope GmbH include ELSA Eckert Life Science Accelerator GmbH.

Will Glycotope GmbH IPO soon?

No public IPO plans have been announced for Glycotope GmbH.

How can I track Glycotope GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Glycotope GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range18
Year Founded2001
Last FundingOct 8, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?